Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis von Dispenzieri, A

Volltext

Systemic amyloidosis from A (AA) to T (ATTR): a review von Muchtar, E., Dispenzieri, A., Magen, H., Grogan, M., Mauermann, M., McPhail, E. D., Kurtin, P. J., Leung, N., Buadi, F. K., Dingli, D., Kumar, S. K., Gertz, M. A.

Volltext

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis von Comenzo, R L, Reece, D, Palladini, G, Seldin, D, Sanchorawala, V, Landau, H, Falk, R, Wells, K, Solomon, A, Wechalekar, A, Zonder, J, Dispenzieri, A, Gertz, M, Streicher, H, Skinner, M, Kyle, R A, Merlini, G

Volltext

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients von Kumar, S K, Dispenzieri, A, Lacy, M Q, Gertz, M A, Buadi, F K, Pandey, S, Kapoor, P, Dingli, D, Hayman, S R, Leung, N, Lust, J, McCurdy, A, Russell, S J, Zeldenrust, S R, Kyle, R A, Rajkumar, S V

Volltext

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma von Larsen, J T, Kumar, S K, Dispenzieri, A, Kyle, R A, Katzmann, J A, Rajkumar, S V

Volltext

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma von Rajkumar, S V, Gupta, V, Fonseca, R, Dispenzieri, A, Gonsalves, W I, Larson, D, Ketterling, R P, Lust, J A, Kyle, R A, Kumar, S K

Volltext

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma von Bianchi, G, Kyle, R A, Larson, D R, Witzig, T E, Kumar, S, Dispenzieri, A, Morice, W G, Rajkumar, S V

Volltext

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma von Gonsalves, W I, Rajkumar, S V, Gupta, V, Morice, W G, Timm, M M, Singh, P P, Dispenzieri, A, Buadi, F K, Lacy, M Q, Kapoor, P, Gertz, M A, Kumar, S K

Volltext

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory... von Dispenzieri, A, Tong, C, LaPlant, B, Lacy, M Q, Laumann, K, Dingli, D, Zhou, Y, Federspiel, M J, Gertz, M A, Hayman, S, Buadi, F, O'Connor, M, Lowe, V J, Peng, K-W, Russell, S J

Volltext

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents von Majithia, N, Rajkumar, S V, Lacy, M Q, Buadi, F K, Dispenzieri, A, Gertz, M A, Hayman, S R, Dingli, D, Kapoor, P, Hwa, L, Lust, J A, Russell, S J, Go, R S, Kyle, R A, Kumar, S K

Volltext

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time von Kumar, S K, Dispenzieri, A, Fraser, R, Mingwei, F, Akpek, G, Cornell, R, Kharfan-Dabaja, M, Freytes, C, Hashmi, S, Hildebrandt, G, Holmberg, L, Kyle, R, Lazarus, H, Lee, C, Mikhael, J, Nishihori, T, Tay, J, Usmani, S, Vesole, D, Vij, R, Wirk, B, Krishnan, A, Gasparetto, C, Mark, T, Nieto, Y, Hari, P, D'Souza, A

Volltext

IMWG consensus on risk stratification in multiple myeloma von Chng, W J, Dispenzieri, A, Chim, C-S, Fonseca, R, Goldschmidt, H, Lentzsch, S, Munshi, N, Palumbo, A, Miguel, J S, Sonneveld, P, Cavo, M, Usmani, S, Durie, B GM, Avet-Loiseau, H

Volltext

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders von Dispenzieri, A, Kyle, R, Merlini, G, Miguel, J S, Ludwig, H, Hajek, R, Palumbo, A, Jagannath, S, Blade, J, Lonial, S, Dimopoulos, M, Comenzo, R, Einsele, H, Barlogie, B, Anderson, K, Gertz, M, Harousseau, J L, Attal, M, Tosi, P, Sonneveld, P, Boccadoro, M, Morgan, G, Richardson, P, Sezer, O, Mateos, M V, Cavo, M, Joshua, D, Turesson, I, Chen, W, Shimizu, K, Powles, R, Rajkumar, S V, Durie, B G M

Volltext

Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort von Kourelis, T V, Dispenzieri, A

Volltext

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis von Gertz, M A, Lacy, M Q, Dispenzieri, A, Kumar, S K, Dingli, D, Leung, N, Hogan, W J, Buadi, F K, Hayman, S R

Volltext

Monoclonal Gammopathy of Undetermined Significance von Dispenzieri, A

Volltext

Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics von Vrana, Julie A, Theis, Jason D, Dasari, Surendra, Mereuta, Oana M, Dispenzieri, Angela, Zeldenrust, Steven R, Gertz, Morie A, Kurtin, Paul J, Grogg, Karen L, Dogan, Ahmet

Volltext

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma von Binder, M, Rajkumar, S V, Ketterling, R P, Greipp, P T, Dispenzieri, A, Lacy, M Q, Gertz, M A, Buadi, F K, Hayman, S R, Hwa, Y L, Zeldenrust, S R, Lust, J A, Russell, S J, Leung, N, Kapoor, P, Go, R S, Gonsalves, W I, Kyle, R A, Kumar, S K

Volltext

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey von Landgren, O, Graubard, B I, Katzmann, J A, Kyle, R A, Ahmadizadeh, I, Clark, R, Kumar, S K, Dispenzieri, A, Greenberg, A J, Therneau, T M, Melton, L J, Caporaso, N, Korde, N, Roschewski, M, Costello, R, McQuillan, G M, Rajkumar, S V

Volltext

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses von Peng, K-W, Myers, R, Greenslade, A, Mader, E, Greiner, S, Federspiel, M J, Dispenzieri, A, Russell, S J

Volltext